Article
|
|
|
Services
|
|
|
Google Scholar
|
|
|
PubMed
|
|
Articles in PubMed by Author:
|
|
PubMed
|  |
|
|
REPLY
Efficacy and Safety of Inhaled Insulin Therapy
Harold Sox, MD, Editor
4 April 2006 | Volume 144 Issue 7 | Page 533
IN RESPONSE:
As a matter of editorial policy, we avoid doing anything that people would interpret as collusion with a commercial company to draw attention to their product. In the case of Rosenstock and colleagues' paper (1), we knew that the FDA had not yet approved inhaled insulin, but we had no idea when it would announce its decision. We could not and did not engineer the publication date to coincide with the FDA announcement.
|
Author and Article Information
|
|---|
Potential Financial Conflicts of Interest: None disclosed.
1. Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549-58. [PMID: 16230721].[Abstract/Free Full Text]
Related articles in Annals:
-
Articles
Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized, Controlled Trial
Julio Rosenstock, Bernard Zinman, Liam J. Murphy, Stephen C. Clement, Paul Moore, C. Keith Bowering, Rosa Hendler, Shu-Ping Lan, AND William T. Cefalu
- Annals 2005 143: 549-558.
[ABSTRACT][SUMMARY][Full Text]